Cargando…

Epigenetic Biomarkers: Potential Applications in Gastrointestinal Cancers

Genetics and epigenetics coregulate the cancer initiation and progression. Epigenetic mechanisms include DNA methylation, histone modification, chromatin remodeling, and noncoding RNAs. Aberrant epigenetic modifications play a fundamental role in the formation of gastrointestinal cancers. Advances i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiaqiu, Jin, Hongchuan, Wang, Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963109/ https://www.ncbi.nlm.nih.gov/pubmed/24729878 http://dx.doi.org/10.1155/2014/464015

Ejemplares similares

Increased Circulating MicroRNA-155 as a Potential Biomarker for Breast Cancer Screening: A Meta-Analysis
por: Wang, Faliang, et al.
Publicado: (2014)

MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
por: Lan, Huiyin, et al.
Publicado: (2015)

Epidermal Stem Cells and Their Epigenetic Regulation
por: Shen, Qi, et al.
Publicado: (2013)

Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics
por: Shi, Rongkai, et al.
Publicado: (2021)

Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection
por: Ma, Yanning, et al.
Publicado: (2013)

Identification of KLK10 as a therapeutic target to reverse trastuzumab resistance in breast cancer
por: Wang, Zhuo, et al.
Publicado: (2016)

Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives
por: Vedeld, Hege Marie, et al.
Publicado: (2017)

Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
por: Qian, Xiaoling, et al.
Publicado: (2017)

Synthetic lethality of glutaminolysis inhibition, autophagy inactivation and asparagine depletion in colon cancer
por: Li, Jiaqiu, et al.
Publicado: (2017)

Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials
por: Lai, Pan, et al.
Publicado: (2021)

Cell Transfer Therapy for Cancer: Past, Present, and Future
por: Qian, Xiaoling, et al.
Publicado: (2014)

Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer
por: Jeon, Mi-Seong, et al.
Publicado: (2016)

β-catenin represses miR455-3p to stimulate m6A modification of HSF1 mRNA and promote its translation in colorectal cancer
por: Song, Ping, et al.
Publicado: (2020)

The regulation of protein translation and its implications for cancer
por: Song, Ping, et al.
Publicado: (2021)

Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker
por: Wang, Rui, et al.
Publicado: (2023)

Potential Epigenetic Biomarkers for Prostate Cancer Screening
por: Bae, Jong-Myon
Publicado: (2018)

Editorial: Epigenetic Modifications in Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2021)

Epigenetic Therapies and Biomarkers in Breast Cancer
por: Brown, Lauren Julia, et al.
Publicado: (2022)

Epigenetic Biomarkers in Cancer
por: Cheng, Yuen Yee, et al.
Publicado: (2018)

Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer
por: Islam Khan, Md Zahirul, et al.
Publicado: (2022)

Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy
por: Gai, Wanxia, et al.
Publicado: (2019)

CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process
por: Dai, Dongjun, et al.
Publicado: (2019)

Histone demethylase lysine demethylase 5B in development and cancer
por: Han, Mengjiao, et al.
Publicado: (2016)

N6-methyladenosine links RNA metabolism to cancer progression
por: Dai, Dongjun, et al.
Publicado: (2018)

Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
por: Berg, Marianne, et al.
Publicado: (2011)

Imaging biomarkers in upper gastrointestinal cancers
por: Gabelloni, Michela, et al.
Publicado: (2019)

New Progress of Epigenetic Biomarkers in Urological Cancer
por: Wu, Peng, et al.
Publicado: (2016)

Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers
por: Li, Meng, et al.
Publicado: (2022)

DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer
por: Leygo, Catherine, et al.
Publicado: (2017)

Exosomes as a Source of Biomarkers for Gastrointestinal Cancers
por: Yu, Jingjing, et al.
Publicado: (2023)

Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets
por: Meseure, Didier, et al.
Publicado: (2015)

Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment
por: Wallace, Robert G., et al.
Publicado: (2016)

Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia
por: Feng, Lifeng, et al.
Publicado: (2017)

Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer
por: Wei, Kuo-Liang, et al.
Publicado: (2019)

Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers
por: Karin-Kujundzic, Valentina, et al.
Publicado: (2019)

Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers
por: Rafikova, Guzel, et al.
Publicado: (2023)

mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment
por: Wang, Zhuo, et al.
Publicado: (2014)

Epigenetic biomarkers in cancer
por: Egger, Gerda
Publicado: (2018)

Cancer Epigenetic Biomarkers
por: Coppedè, Fabio
Publicado: (2023)

Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers
por: Tran, Mita T. M. T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8lgrhibk9jlmtgku53barbj1pg